SCHEMBL7988784

SCHEMBL7988784

O=c1nc(-c2cccc(Cl)c2)[nH]c2ncn(Cc3ccc(F)cc3)c12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.43
USP2 O75604 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
ACP1 P24666 3/20 0.42
GRIN1 Q05586 2/20 0.40
GRIN2B Q13224 2/20 0.40
YTHDC1 Q96MU7 1/20 0.39
PARN O95453 1/20 0.39
CNOT7 Q9UIV1 1/20 0.39
CXCR2 P25025 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
GLA P06280 1/20 0.39
HTT P42858 1/20 0.39
UBE2N P61088 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
GRM5 P41594 1/20 0.39
LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7985362 0.92 GRIN1 (0.45) MAPK1ACP1GRIN1GRIN2BYTHDC1
SCHEMBL7988736 0.92 ACP1 (0.45) MAPK1USP2CYP1A2CYP3A4CYP2C9
SCHEMBL7988820 0.91 MAPK1 (0.48) MAPK1ACP1GRIN1GRIN2BYTHDC1
SCHEMBL7973628 0.90 SMN1; SMN2 (0.48) MAPK1ACP1YTHDC1PARNCNOT7
SCHEMBL7974015 0.90 PARN (0.49) MAPK1USP2CYP1A2CYP2C9CYP2C19
SCHEMBL7987312 0.90 GRIN1 (0.48) MAPK1ACP1GRIN1GRIN2BYTHDC1
SCHEMBL7974418 0.90 CNOT7 (0.39) USP2ACP1PARNCNOT7SMN1; SMN2
SCHEMBL7991600 0.90 ACP1 (0.42) ACP1GRIN1GRIN2BYTHDC1PARN
SCHEMBL7985619 0.89 CNOT7 (0.41) ACP1PARNCNOT7LMNAIDO1
SCHEMBL7986522 0.88 CNOT7 (0.48) MAPK1USP2CYP1A2CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed